- Home
- A-Z Publications
- Current Probiotics
- Issue Home
Current Probiotics - Current Issue
Volume 1, Issue 1, 2024
-
-
Rapid Identification of Lactobacillus acidophilus and Bifidobacterium by a 16S rRNA PCR Method
Authors: Amit Hazra, Pijush K Saha, Dipanwita Bhattacharjee and Barun K. BhattacharyyaBackgroundProbiotics are live microorganisms that, when administered, have beneficial effects on human health. Hence, various probiotic organisms belonging to the genera Lactobacillus and Bifidobacterium are being increasingly used in food and pharmaceutical products. For regulatory compliance, simple and reliable analytical methods are required for selective enumeration of different probiotic organisms present in food and pharmaceutical formulations.
ObjectiveThis study aimed to establish a rapid PCR-based method for the identification and differentiation of Lactobacillus acidophilus and Bifidobacterium strains.
MethodsSpecies-specific and genus-specific primers for Lactobacillus and Bifidobacterium were designed based on their 16S rRNA gene sequence. Genomic DNA of different Lactobacillus and Bifidobacterium strains were subjected to PCR with annealing temperature specific for respective primer pairs.
ResultsLactobacillus acidophilus primers gave positive PCR results only with Lactobacillus acidophilus strains and not with other Lactobacillus species, whereas Bifidobacterium genus-specific primers gave positive PCR results with most of the Bifidobacterium strains.
ConclusionThe three species-specific L. acidophilus primer pairs and three genus-specific primer pairs of Bifidobacterium used in this study could easily identify and differentiate Lactobacillus acidophilus and Bifidobacterium with high specificity.
-
-
-
Probiotics in the Prevention of Mucositis in People Undergoing Curative Radiotherapy for their Head and Neck Cancer: A Mini-Review
Radiotherapy for head and neck cancer (HNC) is associated with a dose-limiting side effect known as radiation-induced oral mucositis (RIOM), which severely diminishes the quality of life for patients. The best part is that this adverse effect has identified risk factors, enabling the implementation of preventative medication to delay/mitigate the ill effects, colonization of opportunistic microbes, and infection. Clinically, several effective strategies have been developed to prevent severe RIOM. However, there are limited options for solutions that are both advantageous and practical while also being cost-effective to implement. Results from well-designed and carried-out research have indicated that probiotics have potential benefits in both the management and prevention of RIOM. Research using animal models and clinical studies has affirmatively shown that the utilization of probiotic organisms can successfully modify the intensity of inflammation by modifying the composition, metabolism, and functional characteristics of natural microbiota. Furthermore, the majority (3 of 4) randomized, double-blind, placebo-controlled studies revealed that probiotics were beneficial in decreasing RIOM. This article collates and examines the scientific observations, addresses the underlying mechanisms, and explores the potential benefits of probiotics in mitigating the occurrence and severity of RIOM.
-
-
-
A Review on Probiotics and Their Role in the Management of Cancer
Authors: Rajshree Dahiya, Sumayya Khan and Sanket KumarProbiotics are advantageous bacteria that provide numerous health benefits to individuals when ingested and help to keep the gut microbiota balance. These beneficial bacteria can be found in food, supplements, and medicines. Foods that contain probiotics include yogurt, tempeh, and miso, while bacteria of lactic acid and bifido are the predominant microbial strains commonly employed in various applications. Due to their potential health benefits and minimal side effects, probiotics are widely accepted globally. Maintaining a balanced gut microbiome is crucial for overall health, and any disturbance in the gut's microbiota can trigger inflammatory immune responses and initiate various diseases such as cancer. Cancer is a grave and frequently fatal illness that impacts a significant number of individuals. It arises due to uncontrolled cell growth and is usually diagnosed at an advanced stage. The disease originates from a single cell and can potentially metastasize, spreading through the body. As of now, cancer has no known cure, and the safety and efficacy of conventional chemotherapies and synthetic drugs employed in its treatment are subject to scrutiny. These treatments can negatively impact a patient's well-being, affect drug resistance, and are often too expensive for many patients to afford. Therefore, researchers are exploring more effective and safe ways to manage cancer. Certain probiotic strains have the potential to be beneficial in preventing cancer or as a complement to traditional chemotherapy by altering gut microbiota and improving the reactions of the body’s defense system. Hence, the review examines the likelihood of probiotics as simply an alternative approach to preventing and treating cancer.
-
-
-
Tuberculosis-related Mood Disorders: Probiotics as a Next-Generation Strategy
Authors: Ankit Bhardwaj and Rachna GuptaIntroductionTuberculosis-related mood disorders are well-known but least researched. As frequent comorbidity of tuberculosis (TB), depression is linked to poor adherence to treatment for a number of illnesses. The exact causal mechanism and pathways behind TB disease and associated mental illnesses are unclear. The disease's severity and duration impact the occurrence of depression, and MDR-TB enhances this risk. To summarise the information on the association between depression and unfavourable outcomes of TB treatment, we carried out a narrative review.
ObjectiveThe objective of this study is to provide an overview of probiotics as a cutting-edge treatment for mood disorders linked to tuberculosis.
MethodsA systematic stepwise online database research was done for systematic reviews, original studies, and review papers published on probiotics and mental disorders associated with tuberculosis in PubMed/MEDLINE, Google Scholar, and Web of Science. The reference lists for these articles were also used as sources for the bibliography.
ResultsThe gut microbiota and the brain are connected by neuroendocrine-immune pathways. The diversity and abundance of microbiota Proteobacteria, Actinobacteria Bacteroides, and Firmicutes are reduced in tuberculosis patients. Through the stimulation of different immunological responses or visceral sensory pathways, these changes in the gut microbiome may be a contributing factor in emotional instability and mood disorders. Probiotics also lessen the stress response caused by cortisol, in addition to releasing neurotransmitters, including GABA, serotonin, noradrenaline, acetylcholine, and dopamine, in various brain regions. Probiotics are the most prevalent in the sensory brain network of the brain, which controls the brain's core processing of emotions and sensations. In addition, they produce short-chain fatty acids (SCAFs) from the bacterial fermentation of fibre in the colon, such as butyrate, which inhibits histone deacetylase, binds to G protein-coupled receptors, and serves as an energy metabolite. Butyrate plays a significant role in maintaining brain health by having antimanic and antidepressant effects. Several clinical research on patients with MDD has revealed that probiotics have favourable effects on depressive symptoms.
ConclusionThe central dopamine system, inflammation, the BDNF system, and the gut-brain axis are all recognised to play crucial roles in the pathogenesis of MDD. Commercial probiotics that generate butyrate-producing SCFAs and those resistant to metabolic disorders (such as Bacteroidetes) may be beneficial for tuberculosis-related MDD during and after treatment. In this situation, using bacteria that produce SCFA could be a cutting-edge method of treating clinical MDD.
-
-
-
Probiotics and Health: A Review
Authors: Priti Tomar, Shikha Sharma and Neha DangiHumans serve as hosts for various species of microorganisms that contribute to the maintenance of human health. The beneficial bacteria residing in our bodies are referred to as probiotics. Besides improving the immune system, probiotics are also capable of warding off various diseases. In recent decades, probiotic microorganisms have emerged as a significant factor in human well-being. Popularly referred to as “health-friendly microorganisms,” they influence health in myriad ways by boosting the immune system, combating intestinal irritation, improving the balance of the gut microbiome, lowering blood pressure, relieving postmenopausal symptoms, and reducing traveler’s diarrhea. The ability of probiotics to compete for the adhesion sites of pathogenic microbes makes them an effective treatment against various intestinal pathogens. Recent studies also advocate their use in the treatment of skin and oral diseases. In addition, the modulation of gut flora by probiotics is being discussed as a possible new solution for treating tension and depression. Ultimately, a cost-effective approach is imperative to improve and maintain fitness in the present competitive environment. This review aims to evaluate the potential benefits of probiotic microorganisms in various disorders, such as gastrointestinal disorders, UTIs, acne, anticancer properties, gut-brain connections, and their possible mode of action.
-
Volumes & issues
Most Read This Month Most Read RSS feed
Most Cited Most Cited RSS feed
-
-
Probiotics and Health: A Review
Authors: Priti Tomar, Shikha Sharma and Neha Dangi
-